Global Epidemiology of Buruli Ulcer, 2010–2017, and Analysis of 2014 WHO Programmatic Targets

• Main Authors: Till F. Omansen, Alfred Erbowor-Becksen, Rie Yotsu, Tjip S. van der Werf, Alexander Tiendrebeogo, Lise Grout, Kingsley Asiedu
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2019-12-01
• Series: Emerging Infectious Diseases
• Subjects: Buruli ulcer; Mycobacterium ulcerans; epidemiology; programmatic targets; World Health Organization; mycobacteria
• Online Access: https://wwwnc.cdc.gov/eid/article/25/12/19-0427_article

Buruli ulcer is a neglected tropical disease caused by Myocobacterium ulcerans; it manifests as a skin lesion, nodule, or ulcer that can be extensive and disabling. To assess the global burden and the progress on disease control, we analyzed epidemiologic data reported by countries to the World Health Organization during 2010–2017. During this period, 23,206 cases of Buruli ulcer were reported. Globally, cases declined to 2,217 in 2017, but local epidemics seem to arise, such as in Australia and Liberia. In 2013, the World Health Organization formulated 4 programmatic targets for Buruli ulcer that addressed PCR confirmation, occurrence of category III (extensive) lesions and ulcerative lesions, and movement limitation caused by the disease. In 2014, only the movement limitation goal was met, and in 2019, none are met, on a global average. Our findings support discussion on future Buruli ulcer policy and post-2020 programmatic targets.